Form 4: Lite Strategy Director Receives Annual Stock Option Grant
Insider Transaction Report
Lite Strategy, Inc. Director Nicholas Glover was granted 55,000 stock options as part of customary annual non-employee director compensation.
Summary
- Nicholas Glover, a Director of Lite Strategy, Inc. (LITS), acquired 55,000 derivative securities in the form of stock options.
- The transaction date for this grant was November 14, 2025.
- Each stock option has an exercise price of $2.02.
- The options represent the right to buy 55,000 shares of Common Stock.
- The options were granted as customary annual compensation for non-employee directors.
- Vesting schedule: 16.66666% vested on the grant date (November 14, 2025), with the remaining shares vesting in equal monthly amounts starting December 14, 2025, and continuing through November 14, 2026.
- The options have an expiration date of November 14, 2035.
- Following this transaction, Nicholas Glover beneficially owns 55,000 derivative securities directly.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as the grant of stock options aligns the director's interests with shareholders and is a routine, expected compensation event, indicating stable corporate governance practices.
Positives
- The grant of stock options aligns the interests of Director Nicholas Glover with those of shareholders, as the value of the options increases with the company's stock price.
- This is a customary annual grant, indicating a consistent approach to non-employee director compensation.
Future Outlook
The vesting schedule for the granted stock options extends through November 2026, indicating a future period during which the director's equity stake will gradually increase, subject to continued service.
Management Comments
- The options represent a 'Customary annual grant to non-employee directors of options to purchase shares of common stock.'
- The options were 'Received as compensation for service on the Board.'
Industry Context
The grant of stock options to non-employee directors is a common practice across various industries, serving as a form of compensation that links director incentives to company performance and shareholder value creation. This aligns with standard corporate governance practices for public companies.
Comparison to Industry Standards
- Granting stock options to non-employee directors is a widely accepted compensation practice, comparable to policies at many publicly traded companies across various sectors.
- The vesting schedule, with an initial immediate vest and subsequent monthly vesting over a year, is a common structure designed to retain directors and align their long-term interests with the company's performance, similar to practices seen at companies like Apple Inc. or Microsoft Corp. for their non-executive board members.
- The 10-year expiration period for the options is also standard for such grants, providing a reasonable window for the options to become in-the-money.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy | The grant of stock options to Nicholas Glover is part of the company's established 'customary annual grant' policy for non-employee directors, reinforcing existing compensation structures. | 11/14/2025 | This practice is standard for aligning director incentives with long-term shareholder value and is a common element of sound corporate governance. |
Related Party Transactions
- The grant of 55,000 stock options to Nicholas Glover, a director, constitutes a related party transaction as it involves compensation provided by the company to a member of its board.
Stakeholder Impact
- Shareholders: The grant aligns the director's financial interests with the company's stock performance, potentially encouraging decisions that enhance shareholder value.
- Employees: No direct impact on employees is indicated by this specific filing.
Next Steps
- The remaining 83.33334% of the options will vest in equal monthly amounts beginning December 14, 2025, and continuing through November 14, 2026.
Key Dates
| Date | Description |
|---|---|
| 11/14/2025 | Date of stock option grant; 16.66666% of options vested. |
| 12/14/2025 | Beginning of equal monthly vesting for the remaining options. |
| 11/14/2026 | Final monthly vesting of the stock options. |
| 11/14/2035 | Expiration date of the stock options. |
| 11/19/2025 | Date the Form 4 was signed by Nicholas Glover. |
Keywords
Lite Strategy Inc, LITS, Nicholas Glover, Stock Options, Director Compensation, Insider Transaction, Form 4, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.